Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib
Crossref DOI link: https://doi.org/10.1007/s00228-015-1831-1
Published Online: 2015-03-11
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Ying
Liu, Yi
Fan, Zai-Wen
Li, Jian
Xu, Guo-Gang
Text and Data Mining valid from 2015-03-11